Pharma channel feed – Endpoints News

Pharma channel feed

Kite gives itself a little more time to finish FDA application for KTE-C19

9 years ago

Biopharma shares rally as Donald Trump scores a stunning upset

9 years ago

Prop 61 goes down in flames, torching a national drug price control model

9 years ago

Public combat over US drug prices centers on Prop 61 as rhetoric heats up to fever pitch

9 years ago

In a squeaker, FDA AdComm votes for an OK of Cempra’s antibiotic

9 years ago

Clinton’s chief strategist urged tough drug stance that aimed straight for the "cost pain point”

9 years ago

FDA officials: There was “no scientific basis” for Duchenne drug OK as Sarepta complained of “dire financial” condition

9 years ago

On the ropes, Infinity gets a deal for duvelisib, with $0 up front as PI3k flounders

9 years ago

Fast biotech: Gilead hands $200M to computational wiz Nimbus as it speeds into PhII NASH trial

9 years ago

SEC wants to sanction a PwC accountant for failing to flag Steven Burrill as he looted a biotech fund

9 years ago

Novartis’s blockbuster CDK 4/6 contender LEE011 gets a VIP countdown at the FDA

9 years ago

VIP Clinton supporter pitched campaign chief Podesta on Canadian price controls for the US

9 years ago

2016's drug pricing headwinds threaten a hurricane of new regulations

9 years ago

After a series of PI3k pileups, Genentech offloads a PhII-ready rival for firesale price

9 years ago

AstraZeneca R&D leader Pangalos warns of a post-Brexit UK research retreat without reimbursement reform

9 years ago

FDA flashes red light on Sanofi manufacturing infraction, threatening a looming blockbuster decision

9 years ago

Humana spells out its conditional Exondys 51 coverage policy — strings attached

9 years ago

Auven Therapeutics sells PhIII dry eye disease drug to Sun for $40M-plus

9 years ago

Novartis promises a speedy CAR-T pitch, boasts about its slate of blockbusters-to-be

9 years ago

Why wait? FDA gives early OK to Merck’s Keytruda for frontline lung cancer

9 years ago

FDA clears Global Blood Therapeutics to focus on key biomarker in pivotal sickle cell trial

9 years ago

Kite CEO Arie Belldegrun preps for a looming date with the FDA as he tackles first-mover advantage in CAR-T

9 years ago

Clinton campaign staff: "We have started the war with pharma!!"

9 years ago

Powerful Dems orchestrated campaign at FDA to provide Biogen drug to a dying, high-profile fundraiser

9 years ago

First page Previous page 337 338 339340341 342 343 Next page Last page